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Abstract
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and has been impli-
cated in inflammatory diseases. However, little is known about the regulation of MIF in adi-
pose tissue and its impact on wound healing. The aim of this study was to investigate MIF
expression in inflamed adipose and determine its role in inflammatory cell recruitment and
wound healing. Adipose tissue was harvested from subcutaneous adipose tissue layers of
24 healthy subjects and from adipose tissue adjacent to acutely inflamed wounds of 21
patients undergoing wound debridement. MIF protein and mRNA expression were mea-
sured by ELISA and RT-PCR. Cell-specific MIF expression was visualized by immunohis-
tochemistry. The functional role of MIF in cell recruitment was investigated by a chemotaxis
assay and by flow cytometry of labeled macrophages that were injected intoMif–/–and wild-
type mice. Wound healing was evaluated by an in vitro scratch assay on human fibroblast
monolayers. MIF protein levels of native adipose tissue and supernatants from acutely
inflamed wounds were significantly elevated when compared to healthy controls. MIF
mRNA expression was increased in acutely inflamed adipose tissue indicating the activa-
tion of MIF gene transcription in response to adipose tissue inflammation. MIF is expressed
in mature adipocytes and in infiltrated macrophages. Peripheral blood mononuclear cell
migration was significantly increased towards supernatants derived from inflamed adipose
tissue. This effect was partially abrogated by MIF-neutralizing antibodies. Moreover, when
compared to wildtype mice,Mif–/–mice showed reduced infiltration of labeled macrophages
into LPS-stimulated epididymal fat pads in vivo. Finally, MIF antibodies partially neutralized
the detrimental effect of MIF on fibroblast wound healing. Our results indicate that increased
MIF expression and rapid activation of the MIF gene in fat tissue adjacent to acute wound
healing disorders may play a role in cell recruitment to the site of inflammation and wound
healing.
PLOS ONE | DOI:10.1371/journal.pone.0137366 September 8, 2015 1 / 18
OPEN ACCESS
Citation: Kim B-S, Rongisch R, Hager S, Grieb G,
Nourbakhsh M, Rennekampff H-O, et al. (2015)
Macrophage Migration Inhibitory Factor in Acute
Adipose Tissue Inflammation. PLoS ONE 10(9):
e0137366. doi:10.1371/journal.pone.0137366
Editor: Makoto Kanzaki, Tohoku University, JAPAN
Received: June 4, 2015
Accepted: August 15, 2015
Published: September 8, 2015
Copyright: © 2015 Kim et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
available in the paper and its Supporting Information
files.
Funding: Bong-Sung Kim is supported by
“START”—a program for young scientists of the
Medical Faculty at the RWTH Aachen University
(Project number: 691346, START 2013-2, https://
www.rwth-aachen.de)–and the Research Fellowship
Program of the German Research Foundation
(Deutsche Forschungsgemeinschaft, DFG, GZ: KI
1973/1-1, www.dfg.de). Norbert Pallua is supported
by DFG grant PA 1271/5-1. Jürgen Bernhagen is
supported by DFG grants SFB-TRR57/P03 and BE
1977/7-1, and by the Interdisciplinary Center for
Introduction
Macrophage migration inhibitory factor (MIF) was initially described in the context of
delayed-type hypersensitivity [1]. Stored in preformed intracellular pools, MIF release is
induced by pro-inflammatory factors such as tumor necrosis factor (TNF)-α, lipopolysaccha-
ride (LPS) or interferon (IFN)-γ [2]. MIF expression in adipose tissue was first reported in the
epididymal fat pad of rats and in 3T3-L1 cells, a commonly used murine preadipocyte cell line
[3]. Cultured human adipocytes and preadipocytes were found to express a significant amount
of MIF which correlated with the body mass index (BMI) of the donor [4]. In 3T3-L1 cells,
MIF has an impact on adipogenesis through inhibition of clonal expansion and expression of
CCAAT/enhancer binding protein (C/EBP) α and C/EBP δ [5]. Furthermore, MIF mRNA up-
regulation is mediated by TNF-α through tyrosine-kinase dependent pathways in 3T3-L1 cells
[6].
MIF is a pro-inflammatory protein and a crucial factor in chronic adipose tissue inflamma-
tion. Numerous studies have focused on its involvement in chronic adipose tissue inflamma-
tion during obesity and insulin resistance while little is known about its role in acute adipose
tissue inflammation [7–10].
In this study, we investigated the role of MIF in acute adipose tissue inflammation during
wound healing disorders. Wound repair is a complex mechanism of tissue restoration after
damage. Not only the epidermis and dermis but also the underlying subcutaneous tissue com-
posed of adipose tissue participates in wound repair [9, 11–13]. Delayed wound healing repre-
sents a relevant entity in Plastic Surgery which can lead to life threatening complications and
extended soft tissue defects requiring complex reconstruction procedures. Levels of MIF in
subcutaneous adipose tissue samples from patients with acute wound healing disorders were
measured and compared to MIF levels of healthy adipose tissue. Contrary to its name, MIF
exhibits chemokine-like functions and recruits leukocytes into the site of inflammation by
binding to its non-cognate receptors CXCR2 and CXCR4 [14]. To better understand the role of
MIF in the recruitment of inflammatory cells into adipose tissue and wound healing, a chemo-
taxis assay, in vivo cell tracking, and a scratch assay was performed.
Methods
Patients
Whole adipose tissue samples were collected from two groups of patients. The first group con-
sisted of 24 patients (8 male and 16 female, mean age: 50.75 ± 14.75 years) undergoing elective
plastic surgery, which included excision of healthy adipose tissue (HAT) from subcutaneous
adipose tissue depots (Table 1).
The second group included 21 patients (9 male and 12 female, mean age: 52.62 ± 16.14
years) with acute wound healing disorders (Table 2).
These were defined as wounds either caused by external trauma, iatrogenic manipulation or
after surgical intervention that showed the classic signs of local inflammation (tumor, calor,
rubor, dolor and functio laesa), negative bacterial swab samples at the time of tissue harvest, did
not exceed a time period of four weeks after trauma or intervention, and needed surgical
debridement. Small blocks of acutely inflamed adipose tissue (IAT) were excised within a
distance of 1 cm to the wound margin. Necrotic fat tissue was discarded. Samples were imme-
diately brought to the laboratory where adipose tissue was minced with scissors. After meticu-
lous removal of blood vessels and connective tissue, the samples were washed and stored for
later analysis. Supernatants were collected from adipose tissue cultivated in medium (DMEM/
Ham’s F-12 supplemented with 0.5% fetal calf serum (FCS), 100 U/mL penicillin, 100 μg/mL
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streptomycin and 1 ng/ml bFGF) for 24 hours. All surgeries were performed in the Department
of Plastic Surgery, Hand Surgery–Burn Center of the RWTH University Hospital Aachen, Ger-
many. The use of human samples was approved by the ethics committee of the RWTH Aachen
University (EK 163/07). All patients provided written consent. All experiments were performed
in compliance with the Declaration of Helsinki Principles.
Detection of total protein contents
Total protein content was measured by the DC Protein Assay (BioRad Laboratories GmBH,
Munich, Germany) according to the manufacturer’s instructions. The colorimetric reaction
was detected at 740 nm using the FLUOstar OPTIMAmicroplate reader (Fluostar Optima;
BMG Labtech, Offenburg, Germany). MIF levels of whole adipose tissue samples assessed by
ELISA were normalized to the total protein contents of each sample.
Sandwich-enzyme-linked immunosorbent assay (ELISA)
ELISA of homogenized whole adipose tissue and supernatants was performed with MAB289
capture (R&D Systems, Abingdon, United Kingdom) and BAF289 detection antibodies (R&D
Systems) as a sandwich-ELISA. The tissue used for our studies was not further manipulated,
digested with collagenase, or cultured and therefore represents the native state.
Table 1. Details of Healthy Adipose Tissue.
Number Age Sex BMI Location
1 33 m 29.9 lower extremity
2 54 m 25.9 face
3 56 f 29.4 face
4 24 m 37.9 abdomen
5 65 m 27.2 face
6 71 f 18.7 lower extremity
7 51 m 28.9 abdomen
8 45 f 29.7 abdomen
9 80 f 44.1 lower extremity
10 54 f 35.4 abdomen
11 31 f 35.4 lower extremity
12 39 f 34.9 abdomen
13 54 f 44.6 abdomen
14 48 m 27.2 upper extremity
15 54 f 25.4 upper extremity
16 74 m 40.12 lower extremity
17 51 f 33.80 upper extremity
18 74 f 30.35 face
19 51 m 32.27 upper extremity
20 38 f 36.00 upper extremity
21 29 f 27.34 lower extremity
22 43 f 28.34 upper extremity
23 56 f 24.80 abdomen
24 43 f 34.05 abdomen
Age, Sex, BMI, and Harvesting Location of Healthy Adipose Tissue.
doi:10.1371/journal.pone.0137366.t001
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Each well was coated overnight with primary antibody solution at a final concentration of
2 μg/ml. Plates were blocked with PBS containing 1% BSA and 5% sucrose for one hour. After
incubating samples for another two hours, secondary antibody was added at a final concentra-
tion of 200 ng/ml. Streptavidin-POD enzyme conjugate (R&D Systems, Abingdon, United
Kingdom, 1 μl/10 ml TBS) was added and left for 20 minutes. Color reaction was determined
by the Substrate Reagent Pack DY999 by R&D Systems (R&D Systems, Abingdon, United
Kingdom). The reaction was terminated after 20 minutes by adding 0,5 M H2SO4 in ddH2O
and plates were read at 450 nm (FLUOstar OPTIMAmicroplate reader). Bacterially expressed
MIF was used as a standard. All assays were carried out in duplicates.
Real time-polymerase chain reaction (RT-PCR)
mRNA from whole adipose tissue for RT-PCR was prepared by the QIAzol Lysis Reagent (Qia-
gen NV, Venlo, Netherlands) and the RNeasy Mini Kit (Qiagen NV, Venlo, Netherlands) fol-
lowing the manufacturer’s instructions.
cDNA synthesis was performed using the First Strand cDNA Synthesis Kit (Thermo Fisher
Scientific Inc, Waltham, USA) following the manufacturer’s instructions.
The resulting cDNA was subject to quantitative RT-PCR using the 2x SensiMix SYBR No-ROX
Kit (Peqlab Biotechnology, Erlangen, Germany), cDNA template, humanMIF-Primer (MIF-For-
ward: CCGGACAGGGTCTACATCAACTATTAC,MIF-Reverse: TAGGCGAAGGTGGAGTT
GTTCC) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)-Primer (GAPDH-Forward:
GCCTCAAGATCATCAGC, GAPDH-Reverse: ACCACTGACACGTTGGC) as an internal
control with an annealing temperature of 60°C (Primer: Eurofins MWGOperon, Ebersberg,
Table 2. Details of acutely inflamed adipose.
Number Age Sex BMI Location Speciﬁcation
1 53 f 25.4 upper extremity wound healing disorder after external trauma
2 25 f 23.4 face postoperative wound healing disorder
3 56 m 17.9 lower extremity Iatrogenic superﬁcial thrombophlebitis
4 68 m 27.8 upper extremity Iatrogenic superﬁcial thrombophlebitis
5 42 m 19.6 upper extrimity wound after external trauma
6 69 m 27.8 lower extremity Iatrogenic superﬁcial thrombophlebitis
7 70 m 34 upper extremity postoperative wound healing disorder
8 38 f 34.72 upper extremity wound healing disorder after external trauma
9 39 f 34.9 abdomen postoperative wound healing disorder
10 74 m 38 lower extremity postoperative wound healing disorder
11 40 f 89 abdomen postoperative wound healing disorder
12 40 m 32.1 abdomen postoperative wound healing disorder
13 52 f 19.4 upper extremity wound healing disorder after external trauma
14 55 m 27.2 lower extremity Iatrogenic superﬁcial thrombophlebitis
15 40 m 32.1 upper extremity postoperative wound healing disorder
16 57 f 29.4 upper extremity postoperative wound healing disorder
17 80 f 33.3 abdomen postoperative wound healing disorder
18 74 m 40.12 lower extremity wound healing disorder after external trauma
19 66 f 58.88 lower extremity wound healing disorder after external trauma
20 38 f 34.89 lower extremity wound healing disorder after external trauma
21 29 f 27.34 upper extremity wound healing disorder after external trauma
Age, Sex, BMI, Harvesting Location, and Speciﬁcation of acutely inﬂamed adipose.
doi:10.1371/journal.pone.0137366.t002
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Germany and Sigma-Aldrich Chemie GmbH, Munich, Germany). Measurements were conducted
with the RotorGene 6000 (Qiagen NV, Venlo, Netherlands).
Immunohistochemistry
Adipose tissue was fixed in 10% formaldehyde, dehydrated and embedded in paraffin. Next,
samples were deparaffinized and rehydrated. To regain immune reactivity, heat induced epi-
tope retrival (IZKF Biomat.-Histofacility, UK Aachen) was performed. To block non-specific
background staining, DAKO Protein Block (DAKO Deutschland GmbH, Hamburg, Germany)
was used.
For fluorescent staining, the primary mouse anti-human-MIF antibody MAB 289 (R&D
Systems, Abingdon, United Kingdom) as well as Alexa Fluor 488 dye (Life Technologies
GmbH, Darmstadt, Germany) was added. Nuclear staining was performed with 4',6-diami-
dino-2-phenylindole (DAPI).
Isolation and cultivation of peripheral blood mononuclear cells (PBMC)
PBMCs were isolated from buffy coats obtained from the Transfusion Medicine/Blood Donation
Service of the RWTH-Aachen University Hospital by the Ficoll-hypaque density-gradient centri-
fugation method. Isolated cells were cultured in RPMI 1640 medium containing 100 U/mL peni-
cillin, 100 μg/mL streptomycin, and supplemented with 10% FCS. After three days of culture,
adherent PBMCs were used for the chemotaxis experiments.
Chemotaxis assay
PBMCmigration was evaluated in 96-well Transwell-plates (pore size: 5 μm, Corning HTS
Transwell-96, Corning, USA). Medium containing 10% FCS served as a positive control (PC),
medium containing 0.5% FCS served as a negative control (NC). Supernatants of HAT or IAT
were collected in medium containing 0.5% FCS. MIF and monocyte chemoattractant protein
(MCP)-1-dependent effects were tested by use of anti-MIF antibodies (NIH/III.D9) and anti-
MCP-1 antibody (Biolegend, San Diego, United States), respectively. The bottom chambers of
the 96 well plate were filled with PC, NC, and samples plus antibodies. Next, 5x104 PBMCs
were added into the upper chamber and the whole plate was incubated for 2.5 hours at 37°C
and 5% CO2. For evaluation, serial images of migrated PBMCs in the bottom chamber were
obtained with an inverted phase contrast microscope (Leica DMI4000 B) followed by cell
counting with the ImageJ software (National Institute of Health, Bethesda, USA).
In vivomodel
Mice. Ten to 12-week-old male C57BL/6 wildtype (WT) andMif–/–mice were used in this
study. WT mice were purchased from Charles River Laboratory (Wilmington, United States).
The generation ofMIF–/–mice was reported earlier [15]. Animals were housed in plastic cages
fed with standard chow and water ad libitum. All animal experiments were approved by Yale
University's Institutional Animal Care and Use Committee (2015–10756).
Macrophage harvest and labeling. Macrophages were collected fromWTmice after
intraperitoneal injection of 5% thioglycollate by peritoneal lavage. Harvested macrophages
were then washed followed by erythrocyte lysis by ACK lysing buffer (BioWhittaker, Walkers-
ville, United States) and finally labeled with fluorescein isothiocyanate (FITC) (Cell Tracker
Green CMFDA Dye, Life Technologies, Carlsbad, United States).
In vivomigration after LPS injection. 5 mg/kg LPS (Sigma Aldrich, St. Louis, United
States) was injected into the epididymal fat pads of WT andMif–/–mice via a small incision
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followed by retro-orbital injection of 2 x 106 FITC-labeled macrophages. After 48 h, mice were
sacrificed and epididymal fat tissue harvested.
Flow cytometry. The content of FITC-positive macrophages in the harvested adipose tis-
sue was measured by flow cytometry as described previously [16]. In short, adipose tissue was
minced and stromal vascular fraction (SVF) cells yielded by digestion with Collagenase Type II
(Sigma Aldrich, St. Louis, United States). Following antibodies were used for surface staining:
CD11b-AlexaFluor700 (eBioscience, San Diego, United States), F4/80-eFluor450 (eBioscience,
San Diego, United States), CD45-APC (Biolegend, San Diego, United States). Analyses were
performed on a LSR II cytometer (BD Bioscience, San Jose, United States).
In vitro wound healing assay. Human dermal fibroblasts were acquired from the Yale
Human Cell Resource Center and cultured in Dulbecco's Modified Eagle Medium (DMEM)
containing 100 U/mL penicillin, 100 μg/mL streptomycin, and supplemented with 10% FCS
[17]. Wound healing of monolayers of human dermal fibroblasts was evaluated by a standard-
ized scratch assay following a previous protocol with medium containing 10% FCS serving as a
PC and medium containing 0% FCS serving as a NC [18]. Fibroblasts were seeded to 80% con-
fluence in 24-well cell culture plates. Cell monolayers were scratched with a p200 pipette tip.
After washing the plates with growth medium, fibroblasts were incubated with sample super-
natants for 16 hours, MIF dependency was evaluated by anti-MIF antibodies (NIH/III.D9)
and the respective isotype control. Experiments were further performed in the presence and
absence of 10μg/ml Mitomycin C (Sigma Aldrich, St. Louis, United States) to discern between
proliferation and migration-related wound healing. Microscopic photographs were taken at
0 hours and 16 hours. Reference points were marked on the bottom of the plate close to the
scratch by a scalpel for exact adjustment during image acquisition [19]. The relative migration
(in the presence of Mitomycin C) and migration plus proliferation distance (in the absence of
Mitomycin C) was deduced from the comparison of the 0 hour and 16 hours pictures by the
Software Photoshop CS5 (Adobe Systems, CA, USA) and presented in arbitrary units.
Statistical analysis
Flow cytometry data were analyzed by the software FlowJo (Ashland, United States). For all
statistical analysis and diagrams, the software GraphPad Prism (GraphPad Software, Inc., La
Jolla, USA) was used. All data were expressed as mean ± SEM. Statistical significance was calcu-
lated by one-way ANOVA in case of three or more variables and t-test in case of two variables
with a p value of< 0.05 considered as significant. Associations between MIF protein levels
from native adipose tissue and the donor’s BMI was described by Spearman’s rank correlation
with calculation of linear regression and 95% confidence interval.
Results
MIF protein levels are increased in native subcutaneous adipose tissue
from IAT
We first measured the level of MIF protein in subcutaneous adipose tissue from healthy
donors. Subcutaneous adipose tissue samples of healthy donor sites contain significant
amounts of MIF (Fig 1A). Next, subcutaneous tissue samples from acutely inflamed donor
sites were investigated for their respective MIF content. Mean levels of MIF protein in IAT
were almost two-fold higher compared to HAT (Fig 1A). The difference was statistically signif-
icant. Similarly, the supernatants of acutely IAT secreted significantly higher amounts of MIF
than supernatants from HAT (Fig 1B).
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Fig 1. Levels of MIF in native HAT and IAT. Adipose tissue from healthy donor sites and acutely inflamed
donor sites were homogenized. MIF levels were measured by ELISA.AMIF levels of native HAT and IAT B
MIF levels of supernatants derived from HAT and IAT. Data are presented in mean MIF concentration ± SEM.
Statistically significant differences are indicated by asterisks (*, P<0.05).
doi:10.1371/journal.pone.0137366.g001
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MIF mRNA expression is increased in native subcutaneous adipose
tissue from IAT
The expression of MIF mRNA of native HAT and IAT was performed by RT-PCR (Fig 2). The
housekeeping gene GAPDH served as an internal control. To relate the data of the control
group to the data of the experimental group in an overall context, the mean value for MIF gene
expression for the control group was standardized to a relative mean value of 100%. The mean
value of the experimental inflammatory group was multiplied by the same factor.
RT-PCR revealed expression of MIF-mRNA in adipose tissue (Fig 2). Importantly, the
mean value for MIF gene expression in IAT was more than five times higher when compared
to HAT. The difference was statistically significant.
MIF is localized in the cytoplasm of native adipocytes and adipose tissue
macrophages (ATM)
MIF expression was evaluated by immunohistochemistry on formalin fixed human fat tissue.
As demonstrated in Fig 3, MIF is detectable in the cytoplasm of adipocytes. Furthermore, MIF
was localized in the cytoplasm of ATMs which infiltrated the adipose tissue and formed
crown-like structures. It is important to note, that MIF protein was detectable only in a subset
of adipocytes and ATMs. Thus, it is conceivable that MIF protein is differentially expressed
throughout human fat tissue.
MIF staining of the lipid vacuoles was not possible due to the fixation process which led to a
complete evacuation of the vacuoles. The comparison of HAT and IAT did not lead to visible
differences in MIF expression of adipocytes or macrophages but showed generally higher ATM
infiltration.
Fig 2. Relative MIF-mRNA expression in HAT and IAT.HAT and IAT were homogenized. MIF-mRNA
levels were measured by RT-PCR. The mean value for MIF gene expression for HAT was standardized to a
relative mean value of 100%. Data are presented in mean% of HAT ± SEM. Statistically significant
differences are indicated by asterisks (*, P<0.05).
doi:10.1371/journal.pone.0137366.g002
MIF in Acute Adipose Tissue Inflammation
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MIF protein levels of HAT but not IAT correlates with the donor’s BMI
Next, we correlated MIF protein levels from native adipose tissue with the BMI of the donor by
Spearman’s rank order correlation and calculated the regression curve with the 95% confidence
interval. MIF protein levels of HAT positively correlate with the donor’s BMI (Fig 4A). The
correlation was statistically significant (p<0.05, Spearman r = 0.39). No significant correlation
was seen in MIF protein levels of IAT and their donor’s BMI (p = 0.32, Spearman r = -0.23)
(Fig 4B).
PBMCmigration is increased towards supernatants derived from IAT
In order to underscore the functional consequences of our observations, we conducted an in
vitro chemotaxis assay (Fig 5). Supernatants of subcutaneous tissue from HAT and IAT were
used to investigate the migration capacity of PBMCs. PBMC migration was higher in response
to supernatants from IAT when compared to supernatants derived from HAT. These results
indicate that soluble factors from the supernatants of HAT and IAT both secrete soluble factors
that stimulate PBMC migration with the inflamed tissue having a higher chemotactic potency.
PBMCmigration is partially abrogated by MIF antibodies
We used anti-MIF and anti-MCP-1 antibodies to examine whether MIF and/or MCP-1 con-
tributed to the pro-migratory effects of the IAT and HAT supernatants. The addition of MIF
and MCP-1 antibodies significantly disrupted PBMCmigration (Fig 5). Anti-MCP1 and anti-
MIF both showed partial inhibition, with the effect being in the same order of magnitude.
When both antibodies were given simultaneously an additive effect was observed.
In vivomacrophage migration is lower in Mif–/–mice
In order to further elucidate the functional role of MIF in inflammatory adipose tissue, we per-
formed an in vivo cell tracking experiment. This method was previously reported for the mea-
surement of ATM accumulation in obese mice [20]. Labeled macrophages were injected into
WT andMif–/–mice after inducing a local inflammatory response in the epididiymal fat pads
by LPS. FITC-positive macrophages recovered from the inflamed fat pads were measured by
flow cytometry. Macrophages were defined as CD45-, CD11b-, and F4/80-positive cells. Results
show a significantly lower number of labeled macrophages inMif–/–mice when compared to
WT mice (Fig 6). Macrophage infiltration of visceral fat was markedly lower in visceral adipose
tissue depots ofMif–/–and WTmice.
Adipose tissue-derived MIF partially inhibits fibroblast migration in an in
vitro scratch assay
An in vitro scratch assay was used to evaluate the role of adipose tissue-derived MIF on the
healing response of fibroblasts. Human dermal fibroblast monolayers were scratched and incu-
bated with supernatants of IAT and HAT. Each experiment was conducted in the presence and
absence of the potent proliferation inhibitor Mitomycin C in order to discern wound healing
by proliferation and migration versusmigration only. In the absence of Mitomycin C, superna-
tants from HAT elicited a significantly higher proliferation and migration of scratched
Fig 3. MIF expression in adipocytes and ATM of HAT and IAT.MIF expression was evaluated by
immunohistochemistry on formalin fixed human fat tissue (200x magnification). MIF is detectable in single
adipocytes (red arrows) and in ATMs infiltrated as crown-like structures (white arrows). A DAPI staining B
MIF-Alexa 488 stainingCOverlay of DAPI and MIF-Alexa 488.
doi:10.1371/journal.pone.0137366.g003
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fibroblast monolayers than IAT (Fig 7). The addition of an anti-MIF antibody significantly led
to a recovery of the proliferation and migration of fibroblasts incubated with IAT supernatants.
When proliferation of fibroblasts was eliminated by addition of Mitomycin C, overall wound
healing was decreased but the effect of anti-MIF remained significant. The results indicate that
MIF has an impact on the migration of fibroblasts.
Fig 4. Correlation of MIF protein with donor’s BMI.MIF protein levels from native adipose tissue were
correlated (Spearman’s rank order correlation) with the BMI of the donor. The linear regression curve is
depicted by a solid line, the 95% confidence interval by a dotted line. AMIF protein levels and BMI from
donors of HAT show a significant positive correlation (p<0.05, Spearman r = 0.39). BMIF protein levels and
BMI from donors of IAT show no significant correlation (p = 0.32, Spearman r = -0.23).
doi:10.1371/journal.pone.0137366.g004
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Fig 5. Chemotaxis of PBMC towards supernatants from HAT and IAT. PBMCmigration was evaluated in
96 well Transwell-plates (pore size: 5 μm). Medium containing 10% FCS served as a positive control (PC),
medium containing 0.5% FCS served as a negative control (NC). Supernatants of HAT and IAT were
collected in medium containing 0.5% FCS. MIF and MCP-1-dependent effects were shown by use of
monoclonal anti-MIF and anti-MCP-1 antibody and an IgG isotype control. The chemotactic index represents
the ability of the sample to induce cell migration. Each sample was normalized to the negative control. Data
are presented in mean chemotactic index ± SEM. Statistically significant differences are indicated by
asterisks (*, p<0.05; **, p<0.01; ***, p<0.001).A PBMCmigration towards supernatants of HAT and IAT
compared to PC and NC. B PBMCmigration toward IAT partially neutralized by MIF and MCP-1 antibodies.
doi:10.1371/journal.pone.0137366.g005
MIF in Acute Adipose Tissue Inflammation
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Discussion
Wound healing is a sequence of complex processes and depends on a myriad of factors. Fat tis-
sue is a critical organ in body homeostasis and the increasing number of obese patients with
impaired wound healing has generated significant interest in the function of adipose tissue dur-
ing wound repair [13, 21]. Subcutaneous adipose tissue as the tissue layer in immediate prox-
imity to the wound or even exposed in deep tissue defects plays a role in wound healing
through soluble factors. In inflamed adipose tissue, impaired vascularity, oxygen tension, infil-
tration by inflammatory cells, cellular as well as molecular alterations jointly have a significant
impact on wound healing. This observation is evidenced by the delayed and poor wound heal-
ing that can occur in obese patients [13, 22]. The regenerative effect of adipose tissue on kerati-
nocyte migration, proliferation, and differentiation or on fibroblasts was documented early [9,
11, 12, 23]. In particular, adipose precursor cells, so called adipose-derived stem cells (ASC),
appear to have a high regenerative capacity in wounds [24, 25].
In this study, we measured MIF protein levels by ELISA andMIF expression by RT-PCR in
human subcutaneous adipose tissue. In contrast to Fain et al. [7] and also Skurk et al. [4], who
both measured the release of MIF by cultured adipocytes, adipose tissue matrix, stromal vascu-
lar fraction, or ASCs, our approach focused primarily on the native status of adipose tissue.
Additionally, we localized MIF in the cytoplasm of native, mature human adipocytes and
Fig 6. Flow cytometry of labeled ATM from epididymal fat pads fromWT andMif-/-mice. FITC-labeled macrophages were injected retro-orbitally into
WT andMif-/- mice after inducing a local inflammation in the epididiymal fat pads by LPS. After 48 hours, mice were sacrificed and FITC-positive
macrophages were measured by flow cytometry. Doublets were excluded by sideward scatter (SSC) and forward scatter (FSC), macrophages were defined
as CD45, CD11b, and F4/80 positive cells. The results show a significant lower number of FITC-positive macrophages inMif-/- mice when compared to WT
mice. Data is presented as % of FITC-positive ATMs ± SEM. Statistically significant differences are indicated by asterisks (*, p<0.05).
doi:10.1371/journal.pone.0137366.g006
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ATMs. MIF was hitherto only stained in cultured human adipocytes, preadipocytes or in the
epididymal fat pad of rats [3, 4].
We further studied the role of MIF in adipose tissue inflammation and mobilization of
inflammatory cells. To date, studies of the role of adipose tissue in inflammation have mainly
concentrated on its function in chronic inflammation during obesity and diabetes mellitus.
Koska et al. observed a positive association of MIF with adipocyte diameter as a measuring unit
Fig 7. In vitro scratch assay of dermal fibroblasts and supernatants from IAT and HAT.Wound healing of human dermal fibroblast monolayers was
evaluated by an in vitro scratch assay. Fibroblasts were incubated with supernatants of samples from IAT and HAT, MIF-dependency was evaluated by anti-
MIF antibodies. Medium containing 10% FCS served as a PC and medium containing 0% FCS served as a NC. Experiments were performed in the presence
(A, B) and absence (C, D) of the proliferation inhibitor Mitomycin C. A Supernatants from IAT show a decreased induction of fibroblast proliferation and
migration (no Mitomycin C). B Fibroblast proliferation and migration is increased by addition of MIF-antibodies (no Mitomycin C).C Supernatants from IAT
show a decreased induction of fibroblast migration (10 μg/ml Mitomycin C). D Fibroblast migration is increased by addition of MIF-antibodies (10 μg/ml
Mitomycin C). All measurements were normalized to the negative control of Fig 7A which was set as 1. Data are presented in relative migration distance of
fibroblasts ± SEM. Statistically significant differences are indicated by asterisks (*, p<0.05; **, p<0.01; ***, p<0.001).
doi:10.1371/journal.pone.0137366.g007
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for obesity accompanied by a negative correlation to hepatic and peripheral insulin action in
primary human adipocytes and cultured preadipocytes [26]. Interestingly, no comparable cor-
relations were observed for MCP-1, MCP-2, macrophage inflammatory protein (MIP)-1α,
MIP1-β, MIP-2, TNF-α, interleukin (IL)-6 or IL-8. Elevated serumMIF levels were described
in obese female patients, suggesting a role for MIF as a potential contributor for the metabolic
syndrome [27]. MIF is the only factor amongst interleukin 1 receptor antagonist (IL-1Ra),
cathepsin S, nerve growth factor (NGF) and IL-18 showing increased release in morbidly obese
patients as described by Fain et al. We show that the MIF content of healthy subcutaneous fat
tissue correlates with the BMI from the donors underpinning the role of MIF in obesity. No sig-
nificant correlation, however, is seen between MIF protein levels of IAT and the donor’s BMI.
The acute up-regulation of MIF in adipose tissue in inflamed wounds appears to mask the
aforementioned correlation.
We highlighted the role of MIF in acute subcutaneous adipose tissue inflammation in the
context of acute wound healing disorders. We demonstrate that subcutaneous adipose tissue
harvested from acutely inflamed wounds show a significantly higher MIF content and expres-
sion than subcutaneous adipose tissue harvested from healthy donor sites. Increased local
expression of MIF was observed in tissue samples from venous ulcers and Emmerson et al. fur-
ther showed that MIF null mice exhibit accelerated wound healing [28]. Grieb et al. observed
that MIF levels are increased in the wound fluid of patients with acute and chronic wounds
[29]. Higher MIF levels were found in exudates from acute wounds, which later healed
uneventfully, than in exudates from chronic wounds.
In order to assess the functional role of MIF in acute wound healing disorders, we first
focused on its ability to mobilize PBMCs to the site of inflammation. The ability of MIF to pro-
mote leukocyte recruitment was described earlier [30]. But in contrast to employing exoge-
nously added cytokines, we used supernatants from whole adipose tissue that secrete a mixture
of soluble factors containing stimulatory and inhibitory effects. MCP-1 is a well-known chemo-
kine and served as a positive control [20]. We showed that PBMC chemotaxis was partially
abrogated by MIF antibodies. Furthermore, our results indicate that MIF and MCP-1 may
have an additive effect on PBMC chemotaxis. The chemotactic effect was not completely neu-
tralized by the combined administration of anti-MIF and anti-MCP-1 antibodies implying that
other soluble factors such as fatty acids may mediate the chemotaxis of inflammatory cells into
adipose tissue [20, 31]. To underscore our in vitro observations, we investigated the accumula-
tion of labeled macrophages into LPS-injected epididymal fat pads of WT andMif–/–mice. LPS
was used as a stimulus to produce local adipose tissue inflammation [32, 33].Mif–/–mice
showed a significantly lower infiltration rate of FITC-labeled macrophages when compared to
WT mice which confirms the potential importance of MIF in cell recruitment to acutely
inflamed adipose tissue. Our findings are in line with Verschuren et al. who observed decreased
macrophage infiltration in white adipose tissue inMif-deficient mice with lower expression of
intercellular adhesion molecule (I-CAM)-1 and CD44, two relevant adhesion molecules induc-
ing monocyte infiltration [34]. Although our immunohistochemical staining showed a higher
ATM infiltration in IAT, an inflammatory-dependent increase of MIF expression in adipocytes
or ATMs could not be demonstrated. Future studies are required to evaluate the source of MIF
secretion in adipose tissue.
Finally, we studied the effect of adipose tissue-derived MIF on wound healing in an in vitro
scratch assay. Results reveal a deleterious effect of IAT-derived MIF on fibroblast wound heal-
ing by influencing fibroblast migration. Based on the current literature, MIF shows a not fully
understood discrepancy between the detrimental and beneficial effects on cutaneous wound
healing and additional research is required to understand the specific actions of adipose-
derived MIF in wound repair [35].
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The present work represents an initial study to elucidate the role of MIF and the underlying
mechanisms in cell recruitment during acute adipose tissue inflammation. Due to the small
number of samples harvested from heterogeneous donor sites with varying backgrounds of the
patients, the results must be interpreted with caution. The LPS used in our in vivo experiment
must be regarded as a simplified model for acute adipose tissue inflammation ignoring the
more complex wound healing disorders of the human samples. MIF antibodies did not
completely inhibit PBMC chemotaxis, indicating that MCP-1, which had a stronger effect than
MIF in our chemotaxis assay, and other chemokines are involved in this process. Our data,
however, motivates to further investigate our observations in more extended studies. An in
vivo wound model, preferably including a conditional knockout ofMif, may help to underscore
the direct role of adipose-tissue-derived MIF in wound healing. Furthermore, more detailed
investigations regarding MIF-ATM interactions, i.e. the role of MIF in ATM polarization, are
desirable.
In conclusion, we showed that MIF mRNA and protein levels are increased in adipose tissue
from inflammatory wounds. Our results additionally show that MIF appears to play a role in
the recruitment of inflammatory cells to the side of acute adipose tissue inflammation and that
MIF derived from inflamed adipose tissue may inhibit wound healing. Therefore, MIF may
function as a possible target for future therapeutic approaches in impaired wound healing.
However, further studies are required to shed light onto the explicit role of adipose-derived
MIF during wound healing and the effect on ATM function.
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